The 5mg dose produced 15.0% average weight loss
In a 72-week clinical trial of adults with obesity or overweight (without diabetes), participants taking the highest approved dose of Zepbound (tirzepatide 15 mg) lost an average of about 21% of their starting body weight
As soon as the supernatant was centrifuged, 400 mL of the supernatant was poured into the corresponding EP tube and stored overnight at 20 C in the refrigerator before being centrifuged at 12,000 r/min for 3 min at 4 C, and approximately 2000 mL of supernatant was collected in the injection bottle liner for on-board analysis
Most patients notice appetite suppression within the first 12 weeks, with measurable weight loss appearing around week 34 as they consistently eat fewer calories
Schedule a consultation with our expert team today
Now that the drugs are so ubiquitous, the questioning of medical consensus seems no longer necessary